These results suggest that endothelial GLS1-driven glutaminolysis is a key player in cardiac angiogenesis post-MI/R, and that improved endothelial glutaminolysis contributes greatly to the angiogenic and cardioprotective effects of SalB. The gene discussed is GLS; the disease is myocardial infarction.